(Q39150951)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28237618%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

title

Updates of the role of oxidative stress in the pathogenesis of ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28237618%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28237618%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

author name string

Michael P Diamond

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28237618%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Nicole M Fletcher

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28237618%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

language of work or name

English

0 references

publication date

23 February 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28237618%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28237618%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

volume

145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28237618%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28237618%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

page(s)

595-602

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28237618%20AND%20SRC:MED&resulttype=core&format=json

Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment

3 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

The role of the fallopian tube in the origin of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Ovarian cancer development and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

OVCAR-3 spheroid-derived cells display distinct metabolic profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Consortium analysis of 7 candidate SNPs for ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Differential gene expression in ovarian carcinoma: identification of potential biomarkers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Specific point mutations in key redox enzymes are associated with chemoresistance in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Myeloperoxidase and free iron levels: potential biomarkers for early detection and prognosis of ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Oxidative stress, inflammation, and cancer: how are they linked?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Paradoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health Implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Oxidative stress and oxidative damage in carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

7 January 2021

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Reactive oxygen species: a breath of life or death?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Antioxidants in Translational Medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

DNA damage and the balance between survival and death in cancer biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Reactive oxygen species: role in the development of cancer and various chronic conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Cancer cell killing via ROS: to increase or decrease, that is the question

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Regulation of matrix metalloproteinase expression in tumor invasion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Dichloroacetate induces apoptosis of epithelial ovarian cancer cells through a mechanism involving modulation of oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Mitochondrial regulation of oxygen sensing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

The role of oxidative stress in the development of cisplatin resistance in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

A Single Nucleotide Polymorphism in Catalase Is Strongly Associated with Ovarian Cancer Survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Evidence of oxidative stress in the circulation of ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Modulation of redox signaling promotes apoptosis in epithelial ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Myeloperoxidase serves as a redox switch that regulates apoptosis in epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

The effects of the inhibition of inducible nitric oxide synthase on angiogenesis of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Nitric oxide is a physiological substrate for mammalian peroxidases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Nitric oxide modulates the catalytic activity of myeloperoxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Association of myeloperoxidase with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Myeloperoxidase metabolizes thiocyanate in a reaction driven by nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Roles of microRNA on cancer cell metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Evidence for an alternative glycolytic pathway in rapidly proliferating cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Tumor cell metabolism: cancer's Achilles' heel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Cancer's molecular sweet tooth and the Warburg effect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Multifaceted roles of glycolytic enzymes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

The pharmacology of dichloroacetate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Superoxide dismutases in malignant cells and human tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Superoxide dismutase as a target for the selective killing of cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Reactive oxygen species in tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Survival benefit of taxane plus platinum in recurrent ovarian cancer with non-clear cell, non-mucinous histology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Adaptation to oxidative stress, chemoresistance, and cell survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Role of glutathione in cancer progression and chemoresistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

SNPs in cancer research and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Oxidative stress and oxidative damage in chemical carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Functional nsSNPs from carcinogenesis-related genes expressed in breast tissue: potential breast cancer risk alleles and their distribution across human populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Significance of blood serum catalase activity and malondialdehyde level for survival prognosis of ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

ROS function in redox signaling and oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Immunotherapy for ovarian cancer: what's next?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Targeting angiogenesis in gynecologic cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Immunotherapeutic approaches to ovarian cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.02.033

10.1016/J.YGYNO.2017.02.033

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28237618%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference